77 related articles for article (PubMed ID: 1906937)
1. A novel autoantibody reactive with a 48 kDa tRNA associated protein in patients with scleroderma.
Miyachi K; Takano S; Mimori T; Yamagata H; Mita S; Matsuoka Y; Irimajiri S; Tani K; Akizuki M; Homma M
J Rheumatol; 1991 Mar; 18(3):373-8. PubMed ID: 1906937
[TBL] [Abstract][Full Text] [Related]
2. Myositis and interstitial lung disease associated with autoantibody to a transfer RNA-related protein Wa.
Kajihara M; Kuwana M; Tokuda H; Yamane K; Kubo M; Hirakata M; Mimori T
J Rheumatol; 2000 Nov; 27(11):2707-10. PubMed ID: 11093458
[TBL] [Abstract][Full Text] [Related]
3. [An autopsied case of progressive systemic sclerosis with anti Wa antibody who showed a rapid progression].
Abe T; Yachi A; Ishii Y; Takeshima Y; Yonezawa K; Ishibashi F; Tosaka M; Tanifuji J; Yoshida Y; Takano S
Ryumachi; 1992 Oct; 32(5):488-94. PubMed ID: 1440086
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of mitochondria autoantigens in progressive systemic sclerosis: identity with the 72,000 dalton autoantigen in primary biliary cirrhosis.
Alderuccio F; Toh BH; Barnett AJ; Pedersen JS
J Immunol; 1986 Sep; 137(6):1855-9. PubMed ID: 3528290
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study on two cases of progressive systemic sclerosis with anti Wa antibody].
Mita S; Adachi M; Tomii M; Matsuoka Y; Irimajiri S; Miyachi K; Takano S; Matsushima H; Hiwatashi T
Ryumachi; 1989 Oct; 29(5):365-70. PubMed ID: 2634885
[TBL] [Abstract][Full Text] [Related]
6. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
Harvey G; Black C; Maddison P; McHugh N
J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
[TBL] [Abstract][Full Text] [Related]
7. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia.
Betteridge Z; Gunawardena H; North J; Slinn J; McHugh N
Rheumatology (Oxford); 2007 Jun; 46(6):1005-8. PubMed ID: 17392287
[TBL] [Abstract][Full Text] [Related]
8. Novel human autoantibodies reactive with 5'-terminal trimethylguanosine cap structures of U small nuclear RNA.
Okano Y; Medsger TA
J Immunol; 1992 Aug; 149(3):1093-8. PubMed ID: 1634764
[TBL] [Abstract][Full Text] [Related]
9. Spectrum and clinical significance of autoantibodies against transfer RNA.
Ohosone Y; Ishida M; Takahashi Y; Matsumura M; Hirakata M; Kawahara Y; Nishikawa T; Mimori T
Arthritis Rheum; 1998 Sep; 41(9):1625-31. PubMed ID: 9751095
[TBL] [Abstract][Full Text] [Related]
10. Scl-86, a marker antigen for diffuse scleroderma.
van Venrooij WJ; Stapel SO; Houben H; Habets WJ; Kallenberg CG; Penner E; van de Putte LB
J Clin Invest; 1985 Mar; 75(3):1053-60. PubMed ID: 3980727
[TBL] [Abstract][Full Text] [Related]
11. Scl-95/100: doublet of endothelial marker autoantigens in progressive systemic sclerosis.
Alderuccio F; Barnett AJ; Campbell JH; Pedersen JS; Toh BH
Clin Exp Immunol; 1986 Apr; 64(1):94-100. PubMed ID: 3089652
[TBL] [Abstract][Full Text] [Related]
12. Anti-NOR 90. A new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin.
Rodriguez-Sanchez JL; Gelpi C; Juarez C; Hardin JA
J Immunol; 1987 Oct; 139(8):2579-84. PubMed ID: 3309055
[TBL] [Abstract][Full Text] [Related]
13. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
14. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary functions in patients with progressive systemic sclerosis].
Takaya M; Ichikawa Y; Shimizu H; Moriuchi J; Uchiyama M; Arimori S
Ryumachi; 1994 Feb; 34(1):2-9. PubMed ID: 8146723
[TBL] [Abstract][Full Text] [Related]
16. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
Kuwana M; Kaburaki J; Medsger TA; Wright TM
Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
18. Nuclear antigen histone H1 is primarily involved in lupus erythematosus cell formation.
Schett G; Steiner G; Smolen JS
Arthritis Rheum; 1998 Aug; 41(8):1446-55. PubMed ID: 9704644
[TBL] [Abstract][Full Text] [Related]
19. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy.
Kaji K; Fujimoto M; Hasegawa M; Kondo M; Saito Y; Komura K; Matsushita T; Orito H; Hamaguchi Y; Yanaba K; Itoh M; Asano Y; Seishima M; Ogawa F; Sato S; Takehara K
Rheumatology (Oxford); 2007 Jan; 46(1):25-8. PubMed ID: 16728436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
